上海交通大学学报(医学版) ›› 2020, Vol. 40 ›› Issue (08): 1075-1080.doi: 10.3969/j.issn.1674-8115.2020.08.012

• 论著·临床研究 • 上一篇    下一篇

典型与非典型抗精神病药对精神分裂症患者认知症状的影响

周绍宇1,冯振晓1,姚晓萍2,王 万1,赵 静3#,易正辉4#   

  1. 1. 上海市金山区精神卫生中心康复病区,上海 201515;2. 上海市金山区精神卫生中心防治科,上海 201515;3. 上海交通大学医学院附属精神卫生中心临床九科,上海 201108;4.上海交通大学医学院附属精神卫生中心临床八科,上海 201108
  • 出版日期:2020-08-28 发布日期:2020-08-28
  • 通讯作者: 易正辉,电子信箱:yizhenghui1971@163.com。赵 静,电子信箱:maggy-1978@163.com。#为共同通信作者。
  • 作者简介:周绍宇(1979—),男,主治医师,学士;电子信箱:zhoushaoyu7926@163.com。
  • 基金资助:
    国家自然科学基金(81671326);上海市科学技术委员会科研计划项目(17411970000)。

Effects of typical or atypical antipsychotics on cognitive symptoms of the patients with schizophrenia

ZHOU Shao-yu1, FENG Zhen-xiao1, YAO Xiao-ping2, WANG Wan1, ZHAO Jing3#, YI Zheng-hui4#   

  1. 1. Rehabilitation Ward, Shanghai Jinshan District Mental Health Center, Shanghai 201515, China; 2. Department for Disease Control and Prevention, Shanghai Jinshan District Mental Health Center, Shanghai 201515, China; 3. Ninth Clinical Department, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 201108, China; 4. Eighth Clinical Department, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 201108, China
  • Online:2020-08-28 Published:2020-08-28
  • Supported by:
    National Natural Science Foundation of China (81671326); Scientific Research Projects of Shanghai Science and Technology Commission (17411970000).

摘要: 目的·比较长期服用典型与非典型抗精神病药对精神分裂症患者精神症状和认知症状影响的差异。方法·纳入上海市金山区精神卫生中心长期住院精神分裂症患者102例,按抗精神病药物使用情况分为典型抗精神病药治疗组(典型组,n=51),及非典型抗精神病药治疗组(非典型组,n=51)。用阳性和阴性症状量表(Positive and Negative Symptom Scale,PANSS)评估精神症状,用重复性成套心理状态测验(Repeatable Battery for the Assessment of Neuropsychological Status,RBANS)评估认知症状。结果·99例患者完成调查(典型组49例,非典型组50例)。PANSS评分:非典型组阴性症状评分低于典型组,差异有统计学意义(P=0.049)。RBANS评分:非典型组RBANS总分及即刻记忆、语言、注意、延时记忆评分均高于典型组,差异有统计学意义(均P<0.05)。结论·与服用典型抗精神病药的患者相比,长期服用非典型抗精神病药的精神分裂症患者认知症状评分较好。

关键词: 精神分裂症, 非典型抗精神病药, 典型抗精神病药, 认知症状, 认知功能

Abstract:

Objective · To compare the effects of long-term use of typical and atypical antipsychotics on cognitive symptoms of the patients with schizophrenia. Methods · One hundred and two long-term inpatients with schizophrenia in Shanghai Jinshan Mental Health Center were included. According to the types of antipsychotics, the inpatients were divided into typical antipsychotics treatment group (typical group) or atypical antipsychotics treatment group (atypical group) with 51 cases each. Mental symptoms were evaluated by Positive and Negative Symptom Scale (PANSS), and cognitive symptoms were evaluated by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Results · Ninety-nine patients completed the investigation (49 cases in typical group and 50 cases in atypical group). PANSS score: the negative symptom score in the atypical group was lower than that in the typical group, and the difference was statistically significant (P=0.049). RBANS score: The total score of RBANS and the scores of immediate memory, language, attention and delayed memory in the atypical group were significantly higher than those in the typical group (all P<0.05). Conclusion · Compared with the patients who take typical antipsychotics, the patients with schizophrenia who take atypical antipsychotics for a long time have better cognitive symptom scores.

Key words: schizophrenia, atypical antipsychotics, typical antipsychotics, cognitive symptoms, cognitive function

中图分类号: